Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, Maria Trojano, Tim spelman, Ih chang, Rachna Kasliwal, Seema Jaitly, Nolan Campbell, Pei-ran Ho, Stephanie Licata, On behalf of the Tysabri Observational Program (TOP) investigators (Allan Kermode is a member). J Neurol Neurosurg Psychiatry 2020;0:1–9. doi:10.1136/jnnp-2019-322326